Jonsson-Funk named fellow of pharmacoepidemiology society; School well represented at Society’s conference
Dr. Michele Jonsson-Funk has been named a fellow of the International Society for Pharmacoepidemiology (ISPE), in recognition of her outstanding contributions to the field and the organization. Epidemiology faculty members and students joined her at the ISPE conference in Prague this week.
Study finds behavioral changes insufficient to prevent early childhood obesity
August 16, 2018 Results from the longest and largest obesity prevention intervention ever tested in young children showed that children and their families in low-income communities were able to make some sustainable behavioral changes to their diet and activity level. In the end, however, rates of early childhood obesity were unchanged.
Diabetes drug therapy found to be easier on eyes than previously suspected
August 2, 2018 New research on the impact of incretin-based therapies (IBTs) in older adults with diabetes shows this type of therapy may not increase the risk for diabetic retinopathy, a complication of diabetes that threatens sight.
Stürmer and team win honorable mention for Ronald D. Mann Best Paper Award
July 31, 2018 A paper co-authored by Dr. Til Stürmer has won an honorable mention for the Ronald D. Mann Best Paper Award for articles published in 2017 by the journal Pharmicoepidemiology and Drug Safety.
MSCR student awarded grants to study post-hospital care utilization for colorectal surgery patients
July 31, 2018 Dr. Stephanie Lumpkin, student in the Master of Science in Clinical Research program at the Gillings School, has been awarded two grants for her study, “Exploring Post-discharge Care Utilization in Colorectal Surgery Patients.”
Researchers conduct most diverse genetic study of female reproductive milestones to date
July 25, 2018 A new study is the first to examine multiple genes that influence the age at which a woman starts her period and experiences menopause among a large sample of United States women of diverse ancestries. The findings highlight the benefits of including diverse populations in studies of the genetics of female growth and development.
Former inmates at high risk for opioid overdose following prison release
July 19, 2018 A recent study in North Carolina found that, in the first two weeks after being released from prison, former inmates were 40 times more likely to die of an opioid overdose than someone in the general population.
Gillings researchers fight emerging diseases
July 5, 2018 Utilizing the expertise of the Baric Lab at the UNC Gillings School, Gilead Sciences is making breakthroughs in developing drugs to fight some of the world’s deadliest viruses. The Gilead broad-spectrum treatment that was tested and proven in the Baric Lab, now known as Remdesivir, was deployed for use in the Ebola outbreak in the Democratic Republic of the Congo.
Study clarifies how genetic variants linked with African ancestry impact heart disease
July 3, 2018 A recent study co-authored by researchers in the Gillings School examined APOL1 genotypes, which are associated with chronic kidney disease in African-Americans. The goal was to clarify earlier, inconsistent findings that the gene’s variants also could influence cardiovascular disease and mortality risk.
UNC, RTI International researchers assess US travelers’ knowledge of Zika virus, willingness to take hypothetical vaccine
July 2, 2018 A collaboration between researchers at the Gillings School, RTI International and UNC's School of Medicine has resulted in the first study to assess and compare United States travelers’ knowledge levels about the Zika virus across three regions, as well as their willingness to take a prophylactic Zika vaccine that currently is in development.
